{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T16:23:00Z","timestamp":1698337380877},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1993,5,1]],"date-time":"1993-05-01T00:00:00Z","timestamp":736214400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[1993,5]]},"DOI":"10.1007\/bf01741088","type":"journal-article","created":{"date-parts":[[2005,6,13]],"date-time":"2005-06-13T15:48:34Z","timestamp":1118677714000},"page":"171-176","source":"Crossref","is-referenced-by-count":11,"title":["Therapeutic effects of a synthetic peptide of C-reactive protein in pre-clinical tumor models"],"prefix":"10.1007","volume":"36","author":[{"given":"Barbara P.","family":"Barna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A.","family":"Eppstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jane","family":"Thomassen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John J.","family":"Nestor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon V.","family":"Medendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharad D.","family":"Deodhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01741088_CR1","first-page":"305","volume":"44","author":"BP Barna","year":"1984","unstructured":"Barna BP, Deodhar SD, Gautam S, Yen-Lieberman B, Roberts D (1984) Macrophage activation and generation of tumoricidal activity by liposome-associated human C-reactive protein. Cancer Res 44: 305","journal-title":"Cancer Res"},{"key":"BF01741088_CR2","first-page":"3959","volume":"47","author":"BP Barna","year":"1987","unstructured":"Barna BP, James K, Deodhar SD (1987) Activation of human monocyte tumoricidal activity by C-reactive protein. Cancer Res 47: 3959","journal-title":"Cancer Res"},{"key":"BF01741088_CR3","first-page":"1","volume":"7","author":"BP Barna","year":"1988","unstructured":"Barna BP, Thomassen MJ, Wiedemann HP, Ahmad M, Deodhar SD (1988) Modulation of human alveolar macrophage tumoricidal activity by C-reactive protein. J Biol Response Mod 7: 1","journal-title":"J Biol Response Mod"},{"key":"BF01741088_CR4","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0196-9781(86)90121-X","volume":"7","author":"R Buchta","year":"1987","unstructured":"Buchta R, Fridkin M, Pontet M, Romeo D (1987) Synthetic peptides from C-reactive protein containing tufsin-related sequences. Peptides 7: 961","journal-title":"Peptides"},{"key":"BF01741088_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4049\/jimmunol.119.1.187","volume":"119","author":"D Claus","year":"1977","unstructured":"Claus D, Siegel J, Petras K, Osmand A, Gewurz H (1977) Interactions of CRP with the first component of human complement. J Immunol 119: 187","journal-title":"J Immunol"},{"key":"BF01741088_CR6","first-page":"447","volume-title":"Liposomes as drug carriers","author":"SD Deodhar","year":"1988","unstructured":"Deodhar SD (1988) Liposomes in macrophage activation by C-reactive protein (CRP): potential for cancer therapy. In: Gregoriadis G (ed) Liposomes as drug carriers. Wiley, New York, p 447"},{"key":"BF01741088_CR7","first-page":"5084","volume":"42","author":"SD Deodhar","year":"1982","unstructured":"Deodhar SD, James K, Chiang T, Edinger M, Barna BP (1982) Inhibition of lung metastases in mice bearing a malignant fibrosarcoma by treatment with liposomes containing human C-reactive protein. Cancer Res 42: 5084","journal-title":"Cancer Res"},{"key":"BF01741088_CR8","first-page":"311","volume":"27","author":"S Deodhar","year":"1986","unstructured":"Deodhar S, Orangio G, Chiang T, Fazio V (1986) Experimental model for adjuvant therapy of colorectal cancer-Inhibition of liver metastases and prolongation of survival by human C-reactive protein. Am Assoc Cancer Res 27: 311","journal-title":"Am Assoc Cancer Res"},{"key":"BF01741088_CR9","first-page":"115","volume":"2","author":"DA Eppstein","year":"1986","unstructured":"Eppstein DA, Van der Pas MA, Fraser-Smith EB, Felgner PL, Kurahara CG, Matthews TR, Waters RV, Venuti M, Jones G, Mehta R, Lopez-Berestein G (1986) Liposome-encapsulated muramyl dipeptide analog enhances nonspecific host immunity. Immunotherapy 2: 115","journal-title":"Immunotherapy"},{"key":"BF01741088_CR10","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.7384789","volume":"208","author":"IJ Fidler","year":"1980","unstructured":"Fidler IJ (1980) Therapy of spontaneous metastases by intravenous injection of liposomes containing lymphokines. Science 208: 1469","journal-title":"Science"},{"key":"BF01741088_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0169-409X(88)90006-3","volume":"2","author":"IJ Fidler","year":"1988","unstructured":"Fidler IJ (1988) Targeting of immunomodulators to mononuclear phagocytes for therapy of cancer. Adv Drug Deliv Res 2: 69","journal-title":"Adv Drug Deliv Res"},{"key":"BF01741088_CR12","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1073\/pnas.78.3.1680","volume":"78","author":"IJ Fidler","year":"1981","unstructured":"Fidler IJ, Sone S, Fogler WE, Barnes ZL (1981) Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide. Proc Natl Acad Sci USA 78: 1680","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01741088_CR13","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.4049\/jimmunol.136.7.2551","volume":"136","author":"BA Fiedel","year":"1986","unstructured":"Fiedel BA, Gewurz H (1986) Cleaved forms of C-reactive protein are associated with platelet inhibition. J Immunol 136: 2551","journal-title":"J Immunol"},{"key":"BF01741088_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00225299","volume":"41","author":"M Fridkin","year":"1981","unstructured":"Fridkin M, Gottlieb P (1981) Tuftsin Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide. Mol Cell Biochem 41: 73","journal-title":"Mol Cell Biochem"},{"key":"BF01741088_CR15","first-page":"560","volume":"8","author":"S Gautam","year":"1989","unstructured":"Gautam S, Deodhar S (1989) Generation of tumoricidal effector cells by human C-reactive protein and muramyl tripeptide: a comparative study. J Biol Response Mod 8: 560","journal-title":"J Biol Response Mod"},{"key":"BF01741088_CR16","first-page":"346","volume":"6","author":"S Gautam","year":"1987","unstructured":"Gautam S, Barna B, Chiang T, Pettay J, Deodhar S (1987) Use of resealed erythrocytes as a delivery system for C-reactive protein (CRP) to generate macrophage-mediated tumoricidal activity. J Biol Response Mod 6: 346","journal-title":"J Biol Response Mod"},{"key":"BF01741088_CR17","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/jnci\/77.3.823","volume":"77","author":"MH Goldrosen","year":"1986","unstructured":"Goldrosen MH, Paolini N Jr, Holyoke ED (1986) Description of a murine model of experimental hepatic metastases. JNCI 77: 823","journal-title":"JNCI"},{"key":"BF01741088_CR18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Statist Assoc 53: 457","journal-title":"J Am Statist Assoc"},{"key":"BF01741088_CR19","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.134.5.3364","volume":"134","author":"JM Kilpatrick","year":"1985","unstructured":"Kilpatrick JM, Volanakis JE (1985) Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein coated cells. J Immunol 134: 3364","journal-title":"J Immunol"},{"key":"BF01741088_CR20","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/infdis\/151.4.704","volume":"151","author":"G Lopez-Berestein","year":"1985","unstructured":"Lopez-Berestein G, Fainstein V, Hopfer R, Mehta K, Sullivan MP, Keating M, Rosenblum MG, Mehta R, Luna M, Hersh EM, Reuben J, Juliano RL, Brody GP (1985) Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer, a preliminary study. J Infect Dis 151: 704","journal-title":"J Infect Dis"},{"key":"BF01741088_CR21","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1084\/jem.169.4.1485","volume":"169","author":"K Matsushima","year":"1989","unstructured":"Matsushima K, Larsen CG, BuBois GC, Oppenheim JJ (1989) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169: 1485","journal-title":"J Exp Med"},{"key":"BF01741088_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1749-6632.1982.tb22153.x","volume":"389","author":"JJ Morley","year":"1982","unstructured":"Morley JJ, Kushner I (1982) Serum C-reactive protein levels in disease. Ann NY Acad Sci 389: 406","journal-title":"Ann NY Acad Sci"},{"key":"BF01741088_CR23","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.4049\/jimmunol.119.5.1611","volume":"119","author":"RF Mortensen","year":"1977","unstructured":"Mortensen RF, Duskiewicz J (1977) Mediation of CRP dependent phagocytosis through mouse macrophage Fc-receptors. J Immunol 119: 1611","journal-title":"J Immunol"},{"key":"BF01741088_CR24","first-page":"1013","volume":"50","author":"GP Murphy","year":"1973","unstructured":"Murphy GP, Hrushesky WJ (1973) A murine renal cell carcinoma. J NCI 50: 1013","journal-title":"J NCI"},{"key":"BF01741088_CR25","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1200\/JCO.1989.7.12.1915","volume":"7","author":"JL Murray","year":"1989","unstructured":"Murray JL, Kleinerman ES, Cunningham JE, Tatom JR, Andrejcio K, Lepe-Zuniga J, Lamki LM, Rosenblum MG, Frost H, Gutterman JU, Fidler IJ, Krakoff IH (1989) Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patients. J Clin Oncol 7: 1915","journal-title":"J Clin Oncol"},{"key":"BF01741088_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0065-2776(08)60379-X","volume":"34","author":"MB Pepys","year":"1983","unstructured":"Pepys MB, Baltz ML (1983) Acute phase proteins with specific reference to C-reactive protein and related proteins (pentraxins) and serum amyloid A protein. Adv Immunol 34: 141","journal-title":"Adv Immunol"},{"key":"BF01741088_CR27","first-page":"4254","volume":"50","author":"R Perez-Soler","year":"1990","unstructured":"Perez-Soler R, Lopez-Berestein G, Lautersztain J, Al-Baker S, Francis K, Macias-Kiger D, Raber MN, Khokhar AR (1990) Phase I clinical and pharmacological study of liposome-entrappedcis-bisneodecanoato-trans-R,R-1-2-diaminocyclohexane platinum (II). Cancer Res 50: 4254","journal-title":"Cancer Res"},{"key":"BF01741088_CR28","first-page":"185","volume":"135","author":"R Peto","year":"1972","unstructured":"Peto R, Peto J (1972) Asymptotically efficient rank invariant test procedures. J R Statist Soc [A] 135: 185","journal-title":"J R Statist Soc [A]"},{"key":"BF01741088_CR29","first-page":"936","volume":"49","author":"NC Phillips","year":"1989","unstructured":"Phillips NC, Tsao MS (1989) Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative. Cancer Res 49: 936","journal-title":"Cancer Res"},{"key":"BF01741088_CR30","first-page":"1412","volume":"42","author":"G Poste","year":"1982","unstructured":"Poste G, Bucana C, Raz A, Bugelski P, Kirsh R, Fidler IJ (1982) Analysis of the fate of systemically administered liposomes and implications for their use in drug delivery. Cancer Res 42: 1412","journal-title":"Cancer Res"},{"key":"BF01741088_CR31","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1016\/S0021-9258(18)48201-4","volume":"262","author":"FA Robey","year":"1987","unstructured":"Robey FA, Ohura K, Futaki S, Fujii N, Yajima H, Goldman N, Jones KD, Wahl S (1987) Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. J Biol Chem 262: 7053","journal-title":"J Biol Chem"},{"key":"BF01741088_CR32","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.143.9.2974","volume":"143","author":"EG Shephard","year":"1989","unstructured":"Shephard EG, Beer SM, Anderson R, Strachan AF, Nel AE, deBeer FC (1989) Generation of biologically active C-reactive protein peptides by a neutral protease on the membrane of phorbol myristate acetate-stimulated neutrophils. J Immunol 143: 2974","journal-title":"J Immunol"},{"key":"BF01741088_CR33","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.145.5.1469","volume":"145","author":"EG Shephard","year":"1990","unstructured":"Shephard EG, Anderson R, Rosen O, Myer MS, Fridkin M, Strachan AF, deBeer FC (1990) Peptides generated from C-reactive protein by a neutrophil membrane protease: amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxis. J Immunol 145: 1469","journal-title":"J Immunol"},{"key":"BF01741088_CR34","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.4049\/jimmunol.125.6.2454","volume":"125","author":"S Sone","year":"1980","unstructured":"Sone S, Fidler IJ (1980) Synergistic activation by lymphokines and muramyl dipeptide of tumoricidal properties in rat alveolar macrophages. J Immunol 125: 2454","journal-title":"J Immunol"},{"key":"BF01741088_CR35","volume-title":"Solid phase peptide synthesis","author":"J Stewart","year":"1984","unstructured":"Stewart J, Young J (1984) Solid phase peptide synthesis. Pierce Chemical Company, Rockford, Ill."},{"key":"BF01741088_CR36","doi-asserted-by":"crossref","unstructured":"Thomassen MJ, Meeker DP, Deodhar SD, Wiedemann HP, Barna BP (1992) Activation of human monocytes and alveolar macrophages by a synthetic peptide of C-reactive protein. J Immunother (in press)","DOI":"10.1097\/00002371-199301000-00001"},{"key":"BF01741088_CR37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00205420","volume":"16","author":"PS Thombre","year":"1984","unstructured":"Thombre PS, Deodhar SD (1984) Inhibition of liver metastases in murine colon adenocarcinoma by liposomes containing human C-reactive protein or crude lymphokine. Cancer Immunol Immunother 16: 145","journal-title":"Cancer Immunol Immunother"},{"key":"BF01741088_CR38","first-page":"353","volume-title":"Liposomes in the therapy of infectious diseases and cancer","author":"J Treat","year":"1989","unstructured":"Treat J, Greenspan AR, Rahman A (1989) Liposome encapsulated doxorubicin: preliminary results of phase I and phase II trials. In: G Lopez-Berestein, IJ Fidler (eds), Liposomes in the therapy of infectious diseases and cancer. Liss, New York, p 353"},{"key":"BF01741088_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","volume":"1","author":"F Wilcoxon","year":"1945","unstructured":"Wilcoxon F (1945) Individual comparisons by ranking methods. Biometric Bull 1: 80","journal-title":"Biometric Bull"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01741088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01741088\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01741088","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01741088.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T10:58:49Z","timestamp":1683111529000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01741088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,5]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1993,5]]}},"alternative-id":["BF01741088"],"URL":"https:\/\/doi.org\/10.1007\/bf01741088","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,5]]}}}